Skip to main content

Utility

  • Faculty Directory
  • Contact Us
  • Virtual Tour
  • Give
Home

Main navigation

  • About Us
    • Leadership and Administration
    • Culture, Engagement, and Impact
    • Facts & Figures
    • History
    • Named Professorships
    • Faculty Resources
    • Staff Resources
    • Duke In Durham
    • Duke Health Virtual Tour
    • Alumni
    • Giving
    • Anatomical Gifts Program
    • Calendar of Events
    • Contact Us
  • Education
    • Health Professions Education Programs
    • Biomedical Graduate Education Programs
    • Biomedical PhD Programs
    • Certificate and Training Programs
    • International Experiences
    • Graduate Medical Education
    • Continuing Medical Education
    • Duke AHEC Program
    • SOM Bulletin
    • Duke Medical Center Library & Archives
  • Research
    • Basic Science Research
    • Clinical and Translational Research
    • Data Science
    • Duke Research and Discovery @RTP
    • Core Facilities & Service Centers
    • Research Initiatives
    • Research Support
    • Nobel Laureates
    • Summer Undergraduate Research Opportunities
    • Research Symposium 2025
  • Patient Care
  • Community Partnership
  • Departments, Centers & Institutes
  • Newsroom
    • News
    • Magnify Magazine
    • DukeMed Alumni News
    • Magazines and Annual Reports
    • Podcasts
    • Video Highlights

Utility

  • Faculty Directory
  • Contact Us
  • Virtual Tour
  • Give
  1. Home
  2. Newsroom
  3. News

News

Communicating Truth. Dr. Cameron Wolfe

Communicating Truth: Dr. Cameron Wolfe

September 27, 2022
Dr. Wolfe emerged as a key figure at Duke during the pandemic, patiently explaining the threat to the public while helping shape both the hospital’s efforts to save patients’ lives and the university’s efforts to keep students safe.
Circulating antibody (white) is prevented from accessing olfactory epithelium (green) by a previously unknown blood-olfactory barrier, the BOB. (Ashley Moseman Lab, Duke University)

Newly Discovered Barrier Prevents Immunity from Reaching Smell-sensing Cells

September 22, 2022
Duke scientists have identified a previously unknown barrier that separates the bloodstream from smelling cells in the upper airway of mice, likely as a way to protect the brain. But this barrier also ends up keeping some of the larger molecules of the body’s immune system out, and that may be hindering the effectiveness of vaccines.
black woman in scrubs and PPE slumped against a wall in exhaustion.

Large Survey Identifies Toll of Pandemic on Health Care Worker Exhaustion

September 21, 2022
COVID exacted a huge toll on the wellbeing of health care workers. Already struggling with high levels of emotional exhaustion going into the pandemic, the problem grew even worse after two years of managing the crisis. Nurses have been especially hard hit.
Sequencing research scientists at work in the lab

Inside the Massive Genome Sequencing Operation Guiding Duke's COVID Response

August 17, 2022
Indy Week explores how a group of genome sequencing research scientists at Duke steered the university's COVID-19 response.
COVID-19 spike protein

DCRI Selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative

August 3, 2022
The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center for large-scale national research studies aimed at understanding and improving the treatment of long COVID.
COVID-19 spike protein

CRISPR Technology Demonstrates Success in Preventing and Treating COVID

July 25, 2022
In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.
Fluticasone Inhaler

Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms

July 14, 2022
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking fluticasone furoate for the treatment of mild-to-moderate COVID-19 symptoms.
COVID-19 spike protein

Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients

July 11, 2022
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
colorful pills and tablets on a surface.

Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms

June 13, 2022
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.
Dr. Adia Ross and Dr. Cameron Wolfe

How to Manage the Next COVID Wave

June 2, 2022
Americans heading to the beach, backyard barbecues or long family road trips this summer might consider packing masks, test kits and a little common sense along with their swim trunks and sunscreen.

Pagination

  • « First First page
  • ‹‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • ›› Next page
  • Last » Last page

Sidebar navigation

  • News
  • Magnify Magazine
  • DukeMed Alumni News
  • Magazines and Annual Reports
  • Podcasts
  • Video Highlights
Communications Contacts

Contact a team member in the Office of Strategic Communications.

Contacts for News and Press Releases

For general communications questions or story ideas, please email SOM-Communications@duke.edu.

Duke University School of Medicine logo

Contact Us 


Give


Twitter Instagram YouTube LinkedIn RSS feed

Terms and Conditions
Accessibility

medschool.duke.edu | duke.edu | dukehealth.org

@2025 Duke University and Duke University Health System. All rights reserved.